Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2008 1
2009 2
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean cepheus investigators[Corporate Author] (1 results)?
Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
Olivier A, Girerd N, Michel JB, Ketelslegers JM, Fay R, Vincent J, Bramlage P, Pitt B, Zannad F, Rossignol P; EPHESUS Investigators. Olivier A, et al. Int J Cardiol. 2017 Aug 15;241:344-350. doi: 10.1016/j.ijcard.2017.02.018. Epub 2017 Feb 8. Int J Cardiol. 2017. PMID: 28284500 Clinical Trial.
Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial.
Adamopoulos C, Ahmed A, Fay R, Angioi M, Filippatos G, Vincent J, Pitt B, Zannad F; EPHESUS Investigators. Adamopoulos C, et al. Eur J Heart Fail. 2009 Nov;11(11):1099-105. doi: 10.1093/eurjhf/hfp136. Eur J Heart Fail. 2009. PMID: 19875410 Free PMC article. Clinical Trial.
Sudden death in patients with myocardial infarction.
Pitt B; EPHESUS Investigators. Pitt B, et al. N Engl J Med. 2005 Sep 22;353(12):1294-7; author reply 1294-7. doi: 10.1056/NEJMc051992. N Engl J Med. 2005. PMID: 16177257 No abstract available.
Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.
Pitt B, White H, Nicolau J, Martinez F, Gheorghiade M, Aschermann M, van Veldhuisen DJ, Zannad F, Krum H, Mukherjee R, Vincent J; EPHESUS Investigators. Pitt B, et al. J Am Coll Cardiol. 2005 Aug 2;46(3):425-31. doi: 10.1016/j.jacc.2005.04.038. J Am Coll Cardiol. 2005. PMID: 16053953 Free article. Clinical Trial.
The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction.
Gheorghiade M, Khan S, Blair JE, Harinstein ME, Krum H, Mukherjee R, Pitt B; Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival (EPHESUS) Investigators. Gheorghiade M, et al. Am Heart J. 2009 Sep;158(3):437-43. doi: 10.1016/j.ahj.2009.07.003. Am Heart J. 2009. PMID: 19699868 Clinical Trial.